Dr. Palmer has presented and published on psychiatric topics across the lifespan including screening for adolescent vaping use, adolescent substance use, opioid use disorder treatments, neurobiological perspectives of mental illness, and methods to reduce medication use for behavioral disturbances in dementia. Today, he continues to evaluate the impact of the COVID-19 pandemic on the treatment delivery of psychiatric and substance use treatment.

Clinically, Dr. Palmer currently practices as a psychiatric mental health nurse practitioner at P.K. Mullick and Associates, treating adult patients for general psychiatric conditions, substance use disorders, and severe persistent mental illness such as schizophrenia. Currently, Dr. Palmer’s clinical interest is using esketamine for treatment resistant depression.